Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia

Male 0301 basic medicine Period (music) [SDV]Life Sciences [q-bio] MESH: Spike Glycoprotein, Coronavirus Evolutionary biology Infectious disease (medical specialty) MESH: Base Sequence FOS: Health sciences spike protein Gene Genetic diversity Agricultural and Biological Sciences Computational biology MESH: Aged, 80 and over COVID-19 Testing Sociology MESH: Child Pathology MESH: COVID-19 Disease DNA sequencing MESH: Phylogeny Child MESH: High-Throughput Nucleotide Sequencing Phylogeny MESH: Aged Aged, 80 and over MESH: Middle Aged Genome Physics High-Throughput Nucleotide Sequencing Life Sciences Middle Aged QR1-502 FOS: Sociology 3. Good health Infectious Diseases MESH: Young Adult whole-genome sequencing Child, Preschool VOIs Spike Glycoprotein, Coronavirus Telecommunications Medicine Female MESH: Genome, Viral MESH: Tunisia MESH: Whole Genome Sequencing Research Article Adult Tunisia MESH: Mutation Adolescent Population Genome, Viral Coronavirus Disease 2019 Research Serogroup Microbiology 03 medical and health sciences Virology Health Sciences Genetics Humans MESH: SARS-CoV-2 Viral Diseases in Livestock and Poultry Biology Aged Demography MESH: Adolescent Genomic Sequencing MESH: Humans Base Sequence SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) MESH: Child, Preschool MESH: COVID-19 Testing VOCs COVID-19 Gastrointestinal Viral Infections and Vaccines Development MESH: Adult Outbreak MESH: Serogroup Acoustics Transmission (telecommunications) Computer science MESH: Male Coronavirus disease 2019 (COVID-19) Whole genome sequencing FOS: Biological sciences Mutation Animal Science and Zoology MESH: Female 2019-20 coronavirus outbreak
DOI: 10.1128/spectrum.00639-21 Publication Date: 2021-11-10T15:31:46Z
ABSTRACT
The method of choice for SARS-CoV-2 variant detection is whole-genome sequencing using next-generation sequencing (NGS) technologies. Resources for this technology remain limited in many low- and middle-income countries, where it is not possible to perform whole-genome sequencing for representative numbers of SARS-CoV-2-positive cases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (9)